JXR Evaluates Asset-Backed Securities Programme on Shanghai Stock Exchange to Trim Leverage

Bulletin Express06-22

Jinxin Fertility Group Limited (JXR) announced that it is assessing the launch of an asset-backed securities programme (ABS Programme) to be listed on the Shanghai Stock Exchange. The initiative would see a single class of asset-backed securities issued against real-estate assets held by the Group’s subsidiary, Shenzhen Hengyu Lianxiang Investment Development Co., Ltd., whose building in Shenzhen’s Futian District currently serves Shenzhen Zhongshan Hospital.

Management expects the proposed transaction to significantly lower the Group’s leverage ratio and enhance capital structure and asset quality. If executed, the deal could be classified as a deemed disposal of Hengyu under Rule 14.29 of the Hong Kong Listing Rules.

Implementation remains contingent on market conditions and approvals from the China Securities Regulatory Commission, the Shanghai Stock Exchange and the Hong Kong Stock Exchange. Detailed terms, including issuance size and timetable, have not yet been finalised. JXR has committed to publishing further updates in accordance with listing requirements.

Shareholders and potential investors are advised that the transaction may or may not proceed, and to exercise caution when dealing in the Company’s securities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1182917919?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-22 21:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1182917919","market":"hk","top_or_hot":-1,"title":"JXR Evaluates Asset-Backed Securities Programme on Shanghai Stock Exchange to Trim Leverage","media":"Bulletin Express","content":"<p>Jinxin Fertility Group Limited (JXR) announced that it is assessing the launch of an asset-backed securities programme (ABS Programme) to be listed on the Shanghai Stock Exchange. The initiative would see a single class of asset-backed securities issued against real-estate assets held by the Group’s subsidiary, Shenzhen Hengyu Lianxiang Investment Development Co., Ltd., whose building in Shenzhen’s Futian District currently serves Shenzhen Zhongshan Hospital.</p>\n<p>Management expects the proposed transaction to significantly lower the Group’s leverage ratio and enhance capital structure and asset quality. If executed, the deal could be classified as a deemed disposal of Hengyu under Rule 14.29 of the Hong Kong Listing Rules.</p>\n<p>Implementation remains contingent on market conditions and approvals from the China Securities Regulatory Commission, the Shanghai Stock Exchange and the Hong Kong Stock Exchange. Detailed terms, including issuance size and timetable, have not yet been finalised. JXR has committed to publishing further updates in accordance with listing requirements.</p>\n<p>Shareholders and potential investors are advised that the transaction may or may not proceed, and to exercise caution when dealing in the Company’s securities.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JXR Evaluates Asset-Backed Securities Programme on Shanghai Stock Exchange to Trim Leverage</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJXR Evaluates Asset-Backed Securities Programme on Shanghai Stock Exchange to Trim Leverage\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-22 21:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Jinxin Fertility Group Limited (JXR) announced that it is assessing the launch of an asset-backed securities programme (ABS Programme) to be listed on the Shanghai Stock Exchange. The initiative would see a single class of asset-backed securities issued against real-estate assets held by the Group’s subsidiary, Shenzhen Hengyu Lianxiang Investment Development Co., Ltd., whose building in Shenzhen’s Futian District currently serves Shenzhen Zhongshan Hospital.</p>\n<p>Management expects the proposed transaction to significantly lower the Group’s leverage ratio and enhance capital structure and asset quality. If executed, the deal could be classified as a deemed disposal of Hengyu under Rule 14.29 of the Hong Kong Listing Rules.</p>\n<p>Implementation remains contingent on market conditions and approvals from the China Securities Regulatory Commission, the Shanghai Stock Exchange and the Hong Kong Stock Exchange. Detailed terms, including issuance size and timetable, have not yet been finalised. JXR has committed to publishing further updates in accordance with listing requirements.</p>\n<p>Shareholders and potential investors are advised that the transaction may or may not proceed, and to exercise caution when dealing in the Company’s securities.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01951","symbol_name":"锦欣生殖","start_time":0,"source_url":"","article_id":"1182917919","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1182917919","pubTimestamp":1782135828,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Jinxin Fertility Group Limited (JXR) announced that it is assessing the launch of an asset-backed securities programme (ABS Programme) to be listed on the Shanghai Stock Exchange. The initiative...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01951":"锦欣生殖"},"translate_title":"JXR评估上海证券交易所的资产支持证券计划以削减杠杆","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01951":1},"content_text":"Jinxin Fertility Group Limited (JXR) announced that it is assessing the launch of an asset-backed securities programme (ABS Programme) to be listed on the Shanghai Stock Exchange. The initiative would see a single class of asset-backed securities issued against real-estate assets held by the Group’s subsidiary, Shenzhen Hengyu Lianxiang Investment Development Co., Ltd., whose building in Shenzhen’s Futian District currently serves Shenzhen Zhongshan Hospital.\nManagement expects the proposed transaction to significantly lower the Group’s leverage ratio and enhance capital structure and asset quality. If executed, the deal could be classified as a deemed disposal of Hengyu under Rule 14.29 of the Hong Kong Listing Rules.\nImplementation remains contingent on market conditions and approvals from the China Securities Regulatory Commission, the Shanghai Stock Exchange and the Hong Kong Stock Exchange. Detailed terms, including issuance size and timetable, have not yet been finalised. JXR has committed to publishing further updates in accordance with listing requirements.\nShareholders and potential investors are advised that the transaction may or may not proceed, and to exercise caution when dealing in the Company’s securities.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1182917919","isCrawlerRequest":true}